Overview
Prima-Pharma offers products such as C Prima 1000, Lutimed Forte, Elektrolity Senior + Magnez, Essenorm Plus and Flexin Forte. Its range also includes C Baby Prima, Sinusystem Zatoki, Raparix C Forte and the Primuś pregnancy test, with an emphasis on product quality and customer care.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2022-02-22. Active
62 2490 0005 0000 4530 2653 1667
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
8 public aid cases recorded, with a total value of $19,087.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 29, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $10,625$10,625 | Prezes Banku Gospodarstwa Krajowego | |
| Jul 9, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | $746$746 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| May 12, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | $746$746 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Krzysztof Jermak (44) | 82 | $1,107.51 | 82% |
Others | 18 | $243.11 | 18% |
The articles of association require company consent for share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fortis Pharmaceuticalssp. z o.o. | $6,911,557.57 | fortispharmaceuticals.pl | ||
| Bestpharmasp. z o.o. | $5,786,190.68 | bestpharma.pl | ||
| Formedicsp. z o.o. | $3,074,896.96 | formedic.pl | ||
| Nutri Partnerssp. z o.o. | $2,916,007.85 | nutripartners.co | ||
| Farmbudsp. z o.o. | $2,476,637.88 | farmbud.eu | ||
| Primasp. z o.o. | $1,738,948.88 | primaczysto.pl | ||
| Primahousesp. z o.o. | $1,216,316.75 | prima-house.com | ||
| Zbadajsiesp. z o.o. | $1,112,372.08 | labhome.pl | ||
| Polsil Biopreparatysp. z o.o. | $952,024.30 | polsil.pl | ||
| Madmedsp. z o.o. | $426,323.50 | madmed.eu |
FAQ
Last updated: 2026-07-11